Medicare Access to GLP-1s for Weight Loss Starting July 1
Published on Β· Source: marketwatch.com
AI Summary
Summarized by AI from the source belowStarting July 1, Medicare beneficiaries who qualify will have access to GLP-1 weight-loss drugs for a cost of $50 per month. This initiative marks a significant change in the coverage of weight management treatments for older Americans. The availability of these drugs could potentially influence the healthcare market by increasing demand for GLP-1 medications. It is important for beneficiaries to be aware of possible side effects associated with these treatments.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
